Fundamental Data for CPHD

CEPHEID IN(NSDQ:CPHD)

Cepheid, Inc. develops, manufactures and markets microfluidic systems that integrate, automate and accelerate biological testing. Their systems are miniaturized instruments that analyze complex biological samples in a disposable cartridge by combining molecular biology with microfluidic technology that processes small quantities of liquid, typically using components fabricated with computer chip technology. These systems rapidly perform all of the steps required to analyze complex biological samples.

# Employees: 473

Address: 904 Caribbean Drive,Sunnyvale,CA,USA

Phone: 408 541-4191

Fax: 408 541-4192

Website: www.cepheid.com

Email: jspark@pnlifesciences.com

Sector: Medical

Industry: MED INSTRUMENTS

Executive Officers

Thomas L. Gutshall (Chmn.; Dir.)

John L. Bishop (C.E.O.; Dir.)

Peter J. Dailey Ph.D (Sr. V.P.; Res. & Devpt.)

Joseph H. Smith (Sr. V.P. Gen. Consl.; Sec.)

Humberto Reyes (Exec. V.P.; Opers.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/4/2010

Mean EPS (Next Qtr): ($0.11)

Mean EPS (Year): ($0.42)

Mean Estimate(Long Term): $15.00

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 10

Shares Performance

Period	CPHD	Compare to S&P
YTD	28.81 %	6.60 %
4 Weeks	-5.51 %	-6.53 %
12 Weeks	7.82 %	1.65 %

Shares Information

Analyst Coverage: Y

Avg Volume: 313846

Shares Outstanding: 58M

Market Cap: $0.78B

52 Week High: $15.85

52 Week Low: $5.03

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 CPHD split by factor of 0.100

Earnings Performance

EPS Growth in Last Quarter: 41.67 %

EPS Growth in Last Year: 36.36 %

Sales Growth in Last Quarter: 1.50 %

Sales Growth in Last Quarter: -7.30 %

Financials

Qtr Book Value: $6.12

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: 4.880